检索范围:
排序: 展示方式:
null
《医学前沿(英文)》 2016年 第10卷 第1期 页码 41-51 doi: 10.1007/s11684-016-0429-z
Midline2 (MID2) is an ubiquitin-conjugating E2 enzyme linked to tumor progression and a novel interacting partner of breast cancer 1, early-onset (BRCA1). However, the role of MID2 in breast cancer remains unknown. This study investigated the expression, prognostic value, and role of MID2 in breast cancer. The expression of MID2 mRNA and protein was significantly upregulated in breast cancer tissue and established cell lines compared with that in normal breast epithelial cells and paired adjacent non-tumor tissue (P<0.001). Immunohistochemical analysis demonstrated that MID2 was overexpressed in 272 of 284 (95.8%) paraffin-embedded, archived breast cancer tissue. Moreover, MID2 expression increased with advanced clinical stage (P<0.001). High MID2 expression was significantly associated with advanced clinical stages and T, N, and M staging (all P<0.05). Univariate and multivariate analyses indicated that high MID2 expression was an independent prognostic factor for poor overall survival in the entire cohort (93.73 vs. 172.1 months; P<0.001, log-rank test) and in subgroups with stages Tis+ I+ II and III+ IV. Furthermore, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide colony formation, and anchorage-independent growth ability assays were conducted. Results showed that siRNA silencing of MID2 expression significantly reduced MCF-7 and MDA-MB-231 cell proliferation in vitro and blocked the growth of MDA-MB-231 cell xenograft tumors in vivo (P<0.05). This study indicated that MID2 may be a novel prognostic marker and interventional target in breast cancer.
关键词: breast cancer MID2 proliferation overall survival xenograft
《医学前沿(英文)》 2022年 第16卷 第4期 页码 610-617 doi: 10.1007/s11684-021-0827-8
关键词: bevacizumab elderly patient advanced non-small-cell lung cancer overall survival toxicity
《能源前沿(英文)》 2022年 第16卷 第1期 页码 49-63 doi: 10.1007/s11708-022-0817-9
Influence of the adjuvant therapy on the survival of patients with stage II pancreatic carcinoma
Xi-Yan WANG, Hai-Jun LI, Dong YAN, Hao WEN, Shu-Yong PENG,
《医学前沿(英文)》 2010年 第4卷 第4期 页码 430-435 doi: 10.1007/s11684-010-0700-7
《化学科学与工程前沿(英文)》 doi: 10.1007/s11705-023-2334-8
关键词: NiFeRuOx nanosheets Ni foam electrocatalysis overall seawater splitting solar-driven system
Multi-stage emergency medicine logistics system optimization based on survival probability
Ke WANG, Yixin LIANG, Lindu ZHAO
《工程管理前沿(英文)》 2017年 第4卷 第2期 页码 221-228 doi: 10.15302/J-FEM-2017020
关键词: emergency medicine logistics ambulance drone survival probability critical illness
null
《医学前沿(英文)》 2016年 第10卷 第2期 页码 191-203 doi: 10.1007/s11684-016-0450-2
The relationship between telomere length and cancer survival has been widely studied. To gain a deeper insight, we reviewed the published studies. A total of 29 studies evaluated telomere length in the peripheral blood; 22 studies evaluated telomere length in the tumor tissue. First, in the peripheral blood studies, for solid tumor patients with shortened telomere length, the combined hazard ratios (HRs) for mortality and tumor progression were 1.21 (95%CI, 1.10–1.32) and 1.71 (95%CI, 1.37–2.13), respectively. Meanwhile, in hematology malignancy, the combined HRs for mortality and tumor progression were 2.83 (95%CI, 2.14–3.74) and 2.65 (95%CI, 2.18–3.22), respectively. Second, in the studies that use tumor tissue, for patients with shortened telomeres, the combined HRs for mortality and tumor progression were 1.26 (95%CI, 0.95–1.66) and 1.65 (95%CI, 1.26–2.15), respectively. In the studies that calculate the telomere length ratios of tumor tissue to adjacent normal mucosa, for patients with lower telomere length ratios, the combined HRs were 0.66 (95%CI, 0.53–0.83) and 0.74 (95%CI, 0.41–1.32) for mortality and tumor progression, respectively. In conclusion, shortened telomere in peripheral blood and tumor tissue might indicate poor survival for cancer patients. However, by calculating the telomere length ratios of tumor tissue to adjacent normal mucosa, the lower ratio might indicate better survival.
《能源前沿(英文)》 2022年 第16卷 第3期 页码 483-491 doi: 10.1007/s11708-022-0813-0
关键词: three-dimensional molybdenum nanomaterials hydrogen evolution reaction oxygen evolution reaction overall water splitting
State-of-the-art progress in overall water splitting of carbon nitride based photocatalysts
Bing LUO, Yuxin ZHAO, Dengwei JING
《能源前沿(英文)》 2021年 第15卷 第1期 页码 600-620 doi: 10.1007/s11708-021-0737-0
关键词: photocatalysis overall water splitting carbon nitride hydrogen
《医学前沿(英文)》 2022年 第16卷 第5期 页码 784-798 doi: 10.1007/s11684-021-0911-0
关键词: uveal melanoma mutant GNAQ/11 palmitoylation BCL2 combination target therapy
null
《医学前沿(英文)》 2013年 第7卷 第1期 页码 138-142 doi: 10.1007/s11684-013-0247-5
It has been demonstrated that single nucleotide polymorphisms (SNPs) of SIPA1 (signal-induced proliferation associated gene 1) are associated with metastatic efficiency in both human and rodents. The purpose of this study was to determine whether SIPA1 545 C>T polymorphism was associated with overall survival in patients with metastatic breast cancer. In this study, SIPA1 545 C>T polymorphism was detected in 185 metastatic breast cancer patients using polymerase chain reaction-restriction fragment length polymorphism assay (PCR-RFLP). Survival curves for patients with SIPA1 545 C>T polymorphism was compared using the Kaplan-Meier method with log-rank tests. We found that SIPA1 545 C>T polymorphism was significantly associated with survival in 185 patients with metastatic breast cancer. Patients with SIPA1545 T/T genotype had a significantly worse overall survival (OS) than did patients with C/T or C/C genotype (50.0% vs. 62.9%, P = 0.042). Moreover, in multivariate analysis, as compared with the C/C or C/T genotype, the T/T genotype remained an independent unfavorable prognostic marker of OS in this cohort (hazard ratio [HR] = 2.16; 95% CI= 1.12–4.15; P = 0.022). Our findings indicate that metastatic breast cancer patients with SIPA1 545 T/T genotype have a poorer survival compared to patients with C/C or C/T genotype.
Intracellular trehalose improves the survival of human red blood cells by freeze-drying
HE Hui, LIU Baolin, HUA Zezhao, LI Chuan, WU Zhengzheng
《能源前沿(英文)》 2007年 第1卷 第1期 页码 120-124 doi: 10.1007/s11708-007-0014-x
《医学前沿(英文)》 doi: 10.1007/s11684-023-0993-y
关键词: uveal melanoma liver-directed therapy immune checkpoint blockade SIRT anti-PD-1 anti-CTLA-4
《化学科学与工程前沿(英文)》 doi: 10.1007/s11705-023-2308-x
关键词: nanoparticle sulfur vacancy porous carbon nanofiber transition metal sulfides electrolysis
Transcriptional modules related to hepatocellular carcinoma survival: coexpression network analysis
null
《医学前沿(英文)》 2016年 第10卷 第2期 页码 183-190 doi: 10.1007/s11684-016-0440-4
We performed weighted gene coexpression network analysis (WGCNA) to gain insights into the molecular aspects of hepatocellular carcinoma (HCC). Raw microarray datasets (including 488 samples) were downloaded from the Gene Expression Omnibus (GEO) website. Data were normalized using the RMA algorithm. We utilized the WGCNA to identify the coexpressed genes (modules) after non-specific filtering. Correlation and survival analyses were conducted using the modules, and gene ontology (GO) enrichment was applied to explore the possible mechanisms. Eight distinct modules were identified by the WGCNA. Pink and red modules were associated with liver function, whereas turquoise and black modules were inversely correlated with tumor staging. Poor outcomes were found in the low expression group in the turquoise module and in the high expression group in the red module. In addition, GO enrichment analysis suggested that inflammation, immune, virus-related, and interferon-mediated pathways were enriched in the turquoise module. Several potential biomarkers, such as cyclin-dependent kinase 1 (CDK1), topoisomerase 2α (TOP2A), and serpin peptidase inhibitor clade C (antithrombin) member 1 (SERPINC1), were also identified. In conclusion, gene signatures identified from the genome-based assays could contribute to HCC stratification. WGCNA was able to identify significant groups of genes associated with cancer prognosis.
关键词: hepatocellular carcinoma coexpression module microarray prognosis
标题 作者 时间 类型 操作
Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer cell proliferation in vitro and in vivo
null
期刊论文
Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer: a retrospective analysis
期刊论文
Recent advances of hydrogen production through particulate semiconductor photocatalytic overall water
期刊论文
Influence of the adjuvant therapy on the survival of patients with stage II pancreatic carcinoma
Xi-Yan WANG, Hai-Jun LI, Dong YAN, Hao WEN, Shu-Yong PENG,
期刊论文
NiFeRuO nanosheets on Ni foam as an electrocatalyst for efficient overall alkaline seawater splitting
期刊论文
Multi-stage emergency medicine logistics system optimization based on survival probability
Ke WANG, Yixin LIANG, Lindu ZHAO
期刊论文
Association between telomere length and survival in cancer patients: a meta-analysis and review of literature
null
期刊论文
Facile route to achieve MoSe-NiSe on nickel foam as efficient dual functional electrocatalysts for overall
期刊论文
State-of-the-art progress in overall water splitting of carbon nitride based photocatalysts
Bing LUO, Yuxin ZHAO, Dengwei JING
期刊论文
Palmitoylation of GNAQ/11 is critical for tumor cell proliferation and survival in GNAQ/11-mutant uveal
期刊论文
Association of SIPA1 545 C>T polymorphism with survival in Chinese women with metastatic breast cancer
null
期刊论文
Intracellular trehalose improves the survival of human red blood cells by freeze-drying
HE Hui, LIU Baolin, HUA Zezhao, LI Chuan, WU Zhengzheng
期刊论文
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint
期刊论文
Sulfur-deficient CoNiS nanoparticles-anchored porous carbon nanofibers as bifunctional electrocatalyst for overall
期刊论文